1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Perez-Molina JA, Pulido F, Di Giambenedetto S, Ribera E, Moreno S, Zamora J, Coscia C, Alejos B, Pitch J, Gatell JM, De Luca A, Arribas JR.

    Individual patient data meta-analysis of randomized controlled trials of dual therapy with a boosted PI plus lamivudine for maintenance of virological suppression: GeSIDA study 9717.

    The Journal of antimicrobial chemotherapy . 73(11): 2927-2935. Nº de citas: 15

    [doi:10.1093/jac/dky299]

  • Crespillo-Andújar C, Venanzi-Rullo E, López-Vélez R, Monge-Maillo B, Norman F, López-Polín A, Pérez-Molina JA.

    Safety Profile of Benznidazole in the Treatment of Chronic Chagas Disease: Experience of a Referral Centre and Systematic Literature Review with Meta-Analysis.

    Drug Safety . 41(11): 1035-1048. Nº de citas: 25

    [doi:10.1007/s40264-018-0696-5]

  • Esteban J, Navas E.

    Treatment of infections caused by nontuberculous mycobacteria.

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 36(9): 586-592. Nº de citas: 7

    [doi:10.1016/j.eimc.2017.10.008]

  • Rojo-Marcos G, Rubio-Muñoz JM, Angheben A, Jaureguiberry S, García-Bujalance S, Tomasoni LR, Rodríguez-Valero N, Ruiz-Giardín JM, Salas-Coronas J, Cuadros-González J, García-Rodríguez M, Molina-Romero I, López-Vélez R, Gobbi F, Calderón-Moreno M, Martin-Echevarría E, Elía-López M, Llovo-Taboada J, TropNet Plasmodium ovale investigator group.

    Prospective comparative multi-centre study on imported Plasmodium ovale wallikeri and Plasmodium ovale curtisi infections.

    MALARIA JOURNAL . 17(1): 399-399. Nº de citas: 14

    [doi:10.1186/s12936-018-2544-6]

  • Iniesta C, Álvarez-Del Arco D, García-Sousa LM, Alejos B, Díaz A, Sanz N, Garrido J, Meulbroek M, Pujol F, Moreno S, Fuster-Ruiz de Apocada MJ, Coll P, Antela A, Del Romero J, Ayerdi O, Riera M, Hernández J, Del Amo J.

    Awareness, knowledge, use, willingness to use and need of Pre-Exposure Prophylaxis (PrEP) during World Gay Pride 2017.

    Plos One . 13(10): . Nº de citas: 14

    [doi:10.1371/journal.pone.0204738]

  • Kumar D, Ferreira VH, Blumberg E, Silveira F, Cordero E, Perez-Romero P, Aydillo T, Danziger-Isakov L, Limaye AP, Carratala J, Munoz P, Montejo M, Lopez-Medrano F, Farinas MC, Gavalda J, Moreno A, Levi M, Fortun J, Torre-Cisneros J, Englund JA, Natori Y, Husain S, Reid G, Sharma TS, Humar A.

    A 5-Year Prospective Multicenter Evaluation of Influenza Infection in Transplant Recipients.

    CLINICAL INFECTIOUS DISEASES . 67(9): 1322-1329. Nº de citas: 86

    [doi:10.1093/cid/ciy294]

  • Valencia La Rosa J, Ryan P, Alvaro-Meca A, Troya J, Cuevas G, Gutiérrez J, Moreno S.

    HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination.

    Plos One . 13(10): . Nº de citas: 9

    [doi:10.1371/journal.pone.0204795]

  • Bermejo M, Ambrosioni J, Bautista G, Climent N, Mateos E, Rovira C, Rodríguez-Mora S, López-Huertas MR, García-Gutiérrez V, Steegmann JL, Duarte R, Cervantes F, Plana M, Miró JM, Alcamí J, Coiras M.

    Evaluation of resistance to HIV-1 infection ex vivo of PBMCs isolated from patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitors.

    BIOCHEMICAL PHARMACOLOGY . 156: 248-264. Nº de citas: 9

    [doi:10.1016/j.bcp.2018.08.031]

  • Manzardo C, Londoño MC, Castells L, Testillano M, Montero JL, Peñafiel J, Subirana M, Moreno A, Aguilera V, González-Diéguez ML, Calvo-Pulido J, Xiol X, Salcedo M, Cuervas-Mons V, Sousa JM, Suarez F, Serrano T, Herrero JI, Jiménez M, Fernandez JR, Giménez C, Del Campo S, Esteban-Mur JI, Crespo G, Moreno A, de la Rosa G, Rimola A, Miro JM, FIPSE LT-HIV investigators.

    Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study.

    AMERICAN JOURNAL OF TRANSPLANTATION . 18(10): 2513-2522. Nº de citas: 23

    [doi:10.1111/ajt.14996]

  • Martín-Dávila P, Norman F, Fortún-Abete J, Píris M, Lovatti R, Rubio JM, Martinez-Pérez A, Graus J, Ta G, Villarubia J, Mahillo B, López-Vélez R.

    Donor-derived multiorgan transmission of mixed P. malariae and P. ovale infection: Impact of globalization on post-transplant infections.

    TRANSPLANT INFECTIOUS DISEASE . 20(5): . Nº de citas: 9

    [doi:10.1111/tid.12938]

  • Peters L, Laut K, Resnati C, Del Campo S, Leen C, Falconer K, Trofimova T, Paduta D, Gatell J, Rauch A, Lacombe K, Domingo P, Chkhartishvili N, Zangerle R, Matulionyte R, Mitsura V, Benfield T, Zilmer K, Khromova I, Lundgren J, Rockstroh J, Mocroft A, EuroSIDA Study Group.

    Uptake of hepatitis C virus treatment in HIV/hepatitis C virus-coinfected patients across Europe in the era of direct-acting antivirals.

    AIDS . 32(14): 1995-2004. Nº de citas: 17

    [doi:10.1097/QAD.0000000000001928]

  • Gol-Montserrat, Jordi, del Llano, Juan E., del Amo, Julia, Campbell, Colin, Navarro, Gemma, Segura, Ferran, Suarez, Ignacio, Teira, Ramon, Branas, Fatima, Serrano-Villar, Sergio, Moreno, Santiago, Morillo, Ramon, Fernandez, Elvira, Paz Marco, Ma, Blanch, Jordi, Castano, Manuel, Pujol, Ferran, Jose Fuster, Ma, Sebastian Hernandez, Juan, Garcia-Goni, Manuel, Nuno-Solinis, Roberto, Elizondo, Nerea.

    HIV in Spain 2017: policies for a new management of chronicity beyond virological control

    REVISTA ESPANOLA DE SALUD PUBLICA . 92: . Nº de citas: 3

  • Del Amo J, Campbell C, Navarro G, Segura F, Suárez I, Teira R, Brañas F, Serrano-Villar S, Moreno S, Morillo R, Román I, Marrugat J, Fernández E, Marco MP, Blanch J, Castaño M, Pujol F, Fuster MJ, Hernández JS, García-Goñi M, Nuño-Solinís R, Elizondo N, Nuño-Solinís JEDL, Gol-Montserrat J.

    VIH en España 2017: políticas para una nueva gestión de la cronicidad más allá del control virológico.

    REVISTA ESPANOLA DE SALUD PUBLICA . 92: .

  • Álvarez Cabo D, Alemany A, Martínez Sesmero JM, Moreno Guillén S.

    Healthcare and economic impact.

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 36 Suppl 1: 19-25.

    [doi:10.1016/S0213-005X(18)30242-8]

  • Moreno S, Berenguer J, Fuster-Ruizdeapodaca MJ, García Ontiveros M.

    Early diagnosis.

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 36 Suppl 1: 35-39.

    [doi:10.1016/S0213-005X(18)30245-3]

  • Portocarrero Nuñez JA, Gonzalez-Garcia J, Berenguer J, Gallego MJV, Loyarte JAI, Metola L, Bernal E, Navarro G, Del Amo J, Jarrín I.

    Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients.

    Medicine . 97(38): . Nº de citas: 4

    [doi:10.1097/MD.0000000000012238]

  • Cobo J.

    A comprehensive approach for the patient with Clostridium difficile infection.

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 31 Suppl 1: 27-31.

  • Pérez-Valero I, Pasquau J, Rubio R, Rivero A, Santos J, Sanz J, Mariño A, Crespo M, Hernández-Quero J, Iribarren JA, Gutiérrez F, Terrón A, Esteban H, Pérez-Molina JA.

    Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial.

    The Journal of antimicrobial chemotherapy . 73(9): 2444-2451. Nº de citas: 5

    [doi:10.1093/jac/dky212]